These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 33837517)
21. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells. Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H Mol Brain; 2012 May; 5():17. PubMed ID: 22613578 [TBL] [Abstract][Full Text] [Related]
22. Method Optimization of Skin Biopsy-Derived Fibroblast Culture for Reprogramming Into Induced Pluripotent Stem Cells. Mommaerts K; Bellora C; Lambert P; Türkmen S; Schwamborn JC; Betsou F Biopreserv Biobank; 2022 Feb; 20(1):12-23. PubMed ID: 34407379 [No Abstract] [Full Text] [Related]
23. Bioinspired 3D Culture in Nanoliter Hyaluronic Acid-Rich Core-Shell Hydrogel Microcapsules Isolates Highly Pluripotent Human iPSCs. Xu J; Shamul JG; Staten NA; White AM; Jiang B; He X Small; 2021 Aug; 17(33):e2102219. PubMed ID: 34260817 [TBL] [Abstract][Full Text] [Related]
24. Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications. Li Y; Li L; Chen ZN; Gao G; Yao R; Sun W Biofabrication; 2017 Jul; 9(3):032001. PubMed ID: 28759433 [TBL] [Abstract][Full Text] [Related]
25. Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions. Gandhi JK; Knudsen T; Hill M; Roy B; Bachman L; Pfannkoch-Andrews C; Schmidt KN; Metko MM; Ackerman MJ; Resch Z; Pulido JS; Marmorstein AD Stem Cells Transl Med; 2019 Jun; 8(6):512-521. PubMed ID: 30768863 [TBL] [Abstract][Full Text] [Related]
26. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells. Stoddard-Bennett T; Reijo Pera R Cells; 2019 Jan; 8(1):. PubMed ID: 30621042 [TBL] [Abstract][Full Text] [Related]
27. Generation and Proteome Profiling of PBMC-Originated, iPSC-Derived Corneal Endothelial Cells. Ali M; Khan SY; Vasanth S; Ahmed MR; Chen R; Na CH; Thomson JJ; Qiu C; Gottsch JD; Riazuddin SA Invest Ophthalmol Vis Sci; 2018 May; 59(6):2437-2444. PubMed ID: 29847650 [TBL] [Abstract][Full Text] [Related]
28. Induced Pluripotent Stem Cells on a Chip: A Self-Contained, Accessible, Pipette-less iPSC Culturing and Differentiation Kit. McMinn P; Guckenberger DJ; Beebe DJ SLAS Technol; 2021 Feb; 26(1):80-91. PubMed ID: 32552316 [TBL] [Abstract][Full Text] [Related]
29. Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells. Yu G; Okawa H; Okita K; Kamano Y; Wang F; Saeki M; Yatani H; Egusa H J Dent Res; 2016 Jan; 95(1):110-8. PubMed ID: 26467419 [TBL] [Abstract][Full Text] [Related]
30. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408 [TBL] [Abstract][Full Text] [Related]
36. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Yuan T; Liao W; Feng NH; Lou YL; Niu X; Zhang AJ; Wang Y; Deng ZF Stem Cell Res Ther; 2013 Jun; 4(3):73. PubMed ID: 23769173 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. Rowland TJ; Blaschke AJ; Buchholz DE; Hikita ST; Johnson LV; Clegg DO J Tissue Eng Regen Med; 2013 Aug; 7(8):642-53. PubMed ID: 22514096 [TBL] [Abstract][Full Text] [Related]
38. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases. Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228 [TBL] [Abstract][Full Text] [Related]
39. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells. Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880 [TBL] [Abstract][Full Text] [Related]
40. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming. Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]